235 related articles for article (PubMed ID: 22748651)
1. Potential role for STAT3 inhibitors in glioblastoma.
Jackson C; Ruzevick J; Amin AG; Lim M
Neurosurg Clin N Am; 2012 Jul; 23(3):379-89. PubMed ID: 22748651
[TBL] [Abstract][Full Text] [Related]
2. The role of Stat3 in glioblastoma multiforme.
Luwor RB; Stylli SS; Kaye AH
J Clin Neurosci; 2013 Jul; 20(7):907-11. PubMed ID: 23688441
[TBL] [Abstract][Full Text] [Related]
3. STAT3 as a Therapeutic Target for Glioblastoma.
Liu Y; Li C; Lin J
Anticancer Agents Med Chem; 2010 Sep; 10(7):512-9. PubMed ID: 20879983
[TBL] [Abstract][Full Text] [Related]
4. Effect of the STAT3 inhibitor STX-0119 on the proliferation of cancer stem-like cells derived from recurrent glioblastoma.
Ashizawa T; Miyata H; Iizuka A; Komiyama M; Oshita C; Kume A; Nogami M; Yagoto M; Ito I; Oishi T; Watanabe R; Mitsuya K; Matsuno K; Furuya T; Okawara T; Otsuka M; Ogo N; Asai A; Nakasu Y; Yamaguchi K; Akiyama Y
Int J Oncol; 2013 Jul; 43(1):219-27. PubMed ID: 23612755
[TBL] [Abstract][Full Text] [Related]
5. The role of STAT3 in glioblastoma progression through dual influences on tumor cells and the immune microenvironment.
Chang N; Ahn SH; Kong DS; Lee HW; Nam DH
Mol Cell Endocrinol; 2017 Aug; 451():53-65. PubMed ID: 28089821
[TBL] [Abstract][Full Text] [Related]
6. Resveratrol suppresses tumorigenicity and enhances radiosensitivity in primary glioblastoma tumor initiating cells by inhibiting the STAT3 axis.
Yang YP; Chang YL; Huang PI; Chiou GY; Tseng LM; Chiou SH; Chen MH; Chen MT; Shih YH; Chang CH; Hsu CC; Ma HI; Wang CT; Tsai LL; Yu CC; Chang CJ
J Cell Physiol; 2012 Mar; 227(3):976-93. PubMed ID: 21503893
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of constitutively active Stat3 suppresses proliferation and induces apoptosis in glioblastoma multiforme cells.
Rahaman SO; Harbor PC; Chernova O; Barnett GH; Vogelbaum MA; Haque SJ
Oncogene; 2002 Dec; 21(55):8404-13. PubMed ID: 12466961
[TBL] [Abstract][Full Text] [Related]
8. Targeting the cytoplasmic and nuclear functions of signal transducers and activators of transcription 3 for cancer therapy.
Germain D; Frank DA
Clin Cancer Res; 2007 Oct; 13(19):5665-9. PubMed ID: 17908954
[TBL] [Abstract][Full Text] [Related]
9. Honokiol inhibits signal transducer and activator of transcription-3 signaling, proliferation, and survival of hepatocellular carcinoma cells via the protein tyrosine phosphatase SHP-1.
Rajendran P; Li F; Shanmugam MK; Vali S; Abbasi T; Kapoor S; Ahn KS; Kumar AP; Sethi G
J Cell Physiol; 2012 May; 227(5):2184-95. PubMed ID: 21792937
[TBL] [Abstract][Full Text] [Related]
10. A novel small molecule inhibitor of signal transducers and activators of transcription 3 reverses immune tolerance in malignant glioma patients.
Hussain SF; Kong LY; Jordan J; Conrad C; Madden T; Fokt I; Priebe W; Heimberger AB
Cancer Res; 2007 Oct; 67(20):9630-6. PubMed ID: 17942891
[TBL] [Abstract][Full Text] [Related]
11. The role of STAT3 activation in modulating the immune microenvironment of GBM.
See AP; Han JE; Phallen J; Binder Z; Gallia G; Pan F; Jinasena D; Jackson C; Belcaid Z; Jeong SJ; Gottschalk C; Zeng J; Ruzevick J; Nicholas S; Kim Y; Albesiano E; Pardoll DM; Lim M
J Neurooncol; 2012 Dec; 110(3):359-68. PubMed ID: 23096132
[TBL] [Abstract][Full Text] [Related]
12. Cellular signaling molecules as therapeutic targets in glioblastoma multiforme.
Jagannathan J; Prevedello DM; Dumont AS; Laws ER
Neurosurg Focus; 2006 Apr; 20(4):E8. PubMed ID: 16709039
[TBL] [Abstract][Full Text] [Related]
13. NF-κB and STAT3 in glioblastoma: therapeutic targets coming of age.
Gray GK; McFarland BC; Nozell SE; Benveniste EN
Expert Rev Neurother; 2014 Nov; 14(11):1293-306. PubMed ID: 25262780
[TBL] [Abstract][Full Text] [Related]
14. Activated STAT3 regulates hypoxia-induced angiogenesis and cell migration in human glioblastoma.
Kang SH; Yu MO; Park KJ; Chi SG; Park DH; Chung YG
Neurosurgery; 2010 Nov; 67(5):1386-95; discussion 1395. PubMed ID: 20871442
[TBL] [Abstract][Full Text] [Related]
15. Knockdown of STAT3 expression by RNAi suppresses growth and induces apoptosis and differentiation in glioblastoma stem cells.
Li GH; Wei H; Lv SQ; Ji H; Wang DL
Int J Oncol; 2010 Jul; 37(1):103-10. PubMed ID: 20514402
[TBL] [Abstract][Full Text] [Related]
16. Effect of the JAK2/STAT3 inhibitor SAR317461 on human glioblastoma tumorspheres.
Mukthavaram R; Ouyang X; Saklecha R; Jiang P; Nomura N; Pingle SC; Guo F; Makale M; Kesari S
J Transl Med; 2015 Aug; 13():269. PubMed ID: 26283544
[TBL] [Abstract][Full Text] [Related]
17. Blockade of TGF-β signaling by the TGFβR-I kinase inhibitor LY2109761 enhances radiation response and prolongs survival in glioblastoma.
Zhang M; Kleber S; Röhrich M; Timke C; Han N; Tuettenberg J; Martin-Villalba A; Debus J; Peschke P; Wirkner U; Lahn M; Huber PE
Cancer Res; 2011 Dec; 71(23):7155-67. PubMed ID: 22006998
[TBL] [Abstract][Full Text] [Related]
18. Antiangiogenic therapies in glioblastoma multiforme.
McNamara MG; Mason WP
Expert Rev Anticancer Ther; 2012 May; 12(5):643-54. PubMed ID: 22594899
[TBL] [Abstract][Full Text] [Related]
19. PI3K-AKT pathway negatively controls EGFR-dependent DNA-binding activity of Stat3 in glioblastoma multiforme cells.
Ghosh MK; Sharma P; Harbor PC; Rahaman SO; Haque SJ
Oncogene; 2005 Nov; 24(49):7290-300. PubMed ID: 16007122
[TBL] [Abstract][Full Text] [Related]
20. Role of macrophage migration inhibitory factor in primary glioblastoma multiforme cells.
Baron N; Deuster O; Noelker C; Stüer C; Strik H; Schaller C; Dodel R; Meyer B; Bacher M
J Neurosci Res; 2011 May; 89(5):711-7. PubMed ID: 21360573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]